RBR-36vxx7进行中（未招募）未知
Squamous cell carcinoma of the skin with metastases to the parotid gland: prognostic factors and survival in a single institution
Giulianno Molina de Melo0 个研究点开始时间: 2020年3月23日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18Y 至 90Y（—）
入选标准
- •all patients with non-melanoma skin cancer squamous cell carcinoma subtype; squamous cell carcinoma histologic variants; from head and neck region; with parotid metastasis; neck metastasis; submitted to surgical treatment with curative intent; with a minimum follow-up of three months
排除标准
- •other histologic subtypes than squamous cell carcinoma; patients who lost follow-up; with incomplete clinical data; submitted to surgery outside institution from their primary or neck; with distant metastasis at first presentation; who refused to participate in the study; who were not submitted to surgery due to advanced clinical status
研究者
相似试验
进行中（未招募）
不适用
Evaluation of factors that worsen survival in metastatic patients of skin carcinomaimmunosuppressionsurgerytransplantationnomogramsE02.095.465.425.450Q65.070C04.557.470.200.400Q65.070.010E01.789.650squamous cell carcinomaRBR-9wt2wjGiulianno Molina de Melo
已完成
不适用
Metastases of cutaneous squamous cell carcinoma in organ transplant recipients - The *SCOPE-ITSCC metastases study*10040900Skin cancersquamous cell carcinomaNL-OMON39568eids Universitair Medisch Centrum300
进行中（未招募）
1 期
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-DEEO Pharma A/S480
进行中（未招募）
1 期
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-FREO Pharma A/S480
进行中（未招募）
不适用
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-GBEO Pharma A/S480